Alzheimer's Patients Treated with INmune Bio's XPro™ Show Reduction in CSF Phospho-Tau and Evidence of Remyelination

Author's Avatar
Sep 01, 2021

XPro™ treatment shows statistically significant decrease in Phospho Tau 217 (pT271) and pT181, and an improvement in an imaging biomarker of myelination.